Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Stelara® (ustekinumab) – Expanded indication
July 29, 2022 - The FDA approved Janssen’s Stelara (ustekinumab), for the treatment of patients 6 years or older with active psoriatic arthritis (PsA).
